India  
 
NewsR.in

Tocilizumab Reduces Risk Of Death In Severe COVID-19 Patients

Video Credit: Wochit Tech - Duration: 00:32s - Published
Tocilizumab Reduces Risk Of Death In Severe COVID-19 Patients

Tocilizumab Reduces Risk Of Death In Severe COVID-19 Patients

Treatment with the drug tocilizumab has been shown to reduce the risk of death among hospitalized patients with severe COVID-19.

Tocilizumab cuts the risk of death by about 30%, according to a study published Tuesday.

The medication, which also goes by the name Actmera is primarily used to treat rheumatoid arthritis.

The medication is an immunosuppressive drug designed to reduce inflammation.


You Might Like


Related videos from verified sources

Cognitive disorders linked to severe COVID-19 risk, suggests study [Video]

Cognitive disorders linked to severe COVID-19 risk, suggests study

Dementia and other cognitive disorders are likely to be risk factors for developing severe COVID-19, according to research from the University of Georgia. The findings highlight the need for special..

Credit: ANI     Duration: 01:23Published
Flu Vaccine May Lower Risk Of Severe Illness From COVID-19 [Video]

Flu Vaccine May Lower Risk Of Severe Illness From COVID-19

People who received the flu vaccine in the year before testing positive for COVID-19 may have a milder case of the virus. Those who received the vaccine are nearly 2 1/2 times less likely to be..

Credit: Wochit     Duration: 00:32Published
Study Finds Taking Aspirin Significantly Lowers Risk Of Complications, Death In Coronavirus Patients [Video]

Study Finds Taking Aspirin Significantly Lowers Risk Of Complications, Death In Coronavirus Patients

A new landmark study at the University of Maryland School of Medicine found that COVID-19 patients taking a daily, low-dose aspirin to protect against cardiovascular disease significantly lowered the..

Credit: WJZ Baltimore     Duration: 02:11Published